Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Koselugo (selumetinib)
i
Other names:
AZD6244, ARRY-886, AZD 6244 HydSulfate, ARRY-142886, NSC-748727, AZD-6244, MK-5618, AZD2644, AR00142886, ARRY142886, ARRY886, AZD142886, AR-00142886, ARRY 142886, ARRY 886, AZD-142886, AZD-2644, AZD 2644, AZD 6244, AZD 142886, MK 5618, AR 00142886, AR 142886 X
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(106)
News
Trials
Company:
AstraZeneca, Merck (MSD), Pfizer
Drug class:
MEK inhibitor
Related drugs:
‹
trametinib (330)
binimetinib (68)
mirdametinib (30)
avutometinib (27)
BAY86-9766 (16)
CI-1040 (15)
tunlametinib (12)
AS703026 (5)
CH4987655 (3)
DS03090629 (3)
LNP3794 (3)
IMM-6-415 (2)
AZD8330 (1)
PD98059 (1)
BI 847325 (0)
GDC-0623 (0)
antroquinonol (0)
MEK Inhibitor (0)
MG-D-1509 (0)
NFX-179 (0)
PF-07799544 (0)
WX-554 (0)
SNR1611 (0)
trametinib (330)
binimetinib (68)
mirdametinib (30)
avutometinib (27)
BAY86-9766 (16)
CI-1040 (15)
tunlametinib (12)
AS703026 (5)
CH4987655 (3)
DS03090629 (3)
LNP3794 (3)
IMM-6-415 (2)
AZD8330 (1)
PD98059 (1)
BI 847325 (0)
GDC-0623 (0)
antroquinonol (0)
MEK Inhibitor (0)
MG-D-1509 (0)
NFX-179 (0)
PF-07799544 (0)
WX-554 (0)
SNR1611 (0)
›
Associations
(106)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF V600E
Glioma
BRAF V600E
Glioma
selumetinib
Sensitive: A2 - Guideline
selumetinib
Sensitive
:
A2
selumetinib
Sensitive: A2 - Guideline
selumetinib
Sensitive
:
A2
BRAF fusion
Glioma
BRAF fusion
Glioma
selumetinib
Sensitive: A2 - Guideline
selumetinib
Sensitive
:
A2
selumetinib
Sensitive: A2 - Guideline
selumetinib
Sensitive
:
A2
KRAS mutation
Non Small Cell Lung Cancer
KRAS mutation
Non Small Cell Lung Cancer
selumetinib
Sensitive: B - Late Trials
selumetinib
Sensitive
:
B
selumetinib
Sensitive: B - Late Trials
selumetinib
Sensitive
:
B
BRAF V600E
Astrocytoma
BRAF V600E
Astrocytoma
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
NF1 mutation
CNS Tumor
NF1 mutation
CNS Tumor
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
KIAA1549-BRAF fusion
Astrocytoma
KIAA1549-BRAF fusion
Astrocytoma
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
KRAS mutation
Non Small Cell Lung Cancer
KRAS mutation
Non Small Cell Lung Cancer
afatinib + selumetinib
Sensitive: C2 – Inclusion Criteria
afatinib + selumetinib
Sensitive
:
C2
afatinib + selumetinib
Sensitive: C2 – Inclusion Criteria
afatinib + selumetinib
Sensitive
:
C2
KIAA1549-BRAF fusion
Glioma
KIAA1549-BRAF fusion
Glioma
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
BRAF mutation
Thyroid Gland Carcinoma
BRAF mutation
Thyroid Gland Carcinoma
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
GNAQ mutation
Melanoma
GNAQ mutation
Melanoma
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
GNA11 mutation
Uveal Melanoma
GNA11 mutation
Uveal Melanoma
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
NRAS mutation
Thyroid Gland Carcinoma
NRAS mutation
Thyroid Gland Carcinoma
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
selumetinib
Sensitive: C2 – Inclusion Criteria
selumetinib
Sensitive
:
C2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.